Individualized Medication Guidance for Gastrointestinal Cancer

Minimum Order: 1

Packaging: N/A

Delivery: 15 Days

This test detects 84 genes related to gastrointestinal cancer, provides information on targeted drug, chemotherapy, and hereditary risk assessment.

Features of Individualized Medication Guidance for Gastrointestinal Cancer Treatment

Targeted drug

Gastrointestinal targeted drug gene loci and related pathway genes.

Suggesting targeted drug use and clinical trial information.

Chemotherapy

Suggesting the efficacy and side effects of chemotherapy drugs for gastrointestinal tumors.

Hereditary-related genes

Detect germline variant information, including Lynch syndrome-related genes.

Suggesting pathogenic and suspected pathogenic mutations.

Applicable Population of Individualized Medication Guidance for Gastrointestinal Cancer

Patients with advanced and newly diagnosed gastrointestinal tumors who need targeted drugs.

Patients with recurrent, drug-resistant gastrointestinal tumors.

Gastrointestinal cancer patients requiring targeted drug therapy via liquid biopsy.

Specification of Individualized Medication Guidance for Gastrointestinal Cancer

Sample types Tissue + venous blood / Paraffin section + venous blood / Pleural fluid and ascites + venous blood / Venous blood

TAT 10 days

If you want to know more types of gastrointestinal cancer, please visit our website.

As a biochip company, we can offer medical consumbles for sale, if you have needs, please contact us.

Country: China (Mainland)
Business Type:
Market:
Founded Year:
Address:Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing
Contact:capitalbio technology

Individualized Medication Guidance for Gastrointestinal Cancer

more images of Individualized Medication Guidance for Gastrointestinal Cancer

*Your name:	Enter name here eg:Ralph zhang
*Your Email:	Enter email here
*To:	CapitalBio Technology Co., Ltd.
*Subject:
*Message:
	Enter between 20 to 3,000 characters. English only. Characters : 0 / 3000
*Enter the secure code shown below	Reload Image

		We do inquire for you , please wait ...

Next Generation Sequencing Platform

Neuromuscular Disorders

Mycobacteria Species Identification

Mycobacteria Nucleic Acid Detection

Karyotype Analysis

Individualized Medication Guidance for Prostate Cancer

This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients. Features of Individualized Medication ...

CapitalBio Technology Co., Ltd.

Individualized Medication Guidance for Gynecologic Cancer

Gynecologic Cancer Surgery According to the latest Chinese women\'s new cancer statistics, cervical cancer and ovarian cancer are in the top ten new cases of female cancer (about 110,000 and 60,000 respectively). With the widespread clinical use of poly(ADP-ribose) polymerase ...

CapitalBio Technology Co., Ltd.

Individualized Medication Guidance for Cancer (800 Genes)

This test detects 800 genes related to targeted therapy, chemotherapy and endocrine drug, hereditary tumor, immunotherapy-related information (MSI and TMB), tumor core signaling pathway and tumor prognosis. The types of variants detected include SNV, InDel, amplifications and ...

CapitalBio Technology Co., Ltd.

Individualized Medication Guidance for Cancer (118 Genes)

This cancer genetic test detects 136 genes, including 110 targeted drug-related genes and 27 chemotherapy drug-related genes, provides the correlation between gene mutations and targeted drugs and chemotherapy drugs based on clinical data, and assists doctors to formulate ...

CapitalBio Technology Co., Ltd.